Announcements Trials
Browse Landscape

Phase

Phase 2 69Phase NA 15Phase 3 14Phase 1/2 12Phase 1 10Phase 2/3 8Phase 4 6Phase EARLY_PHASE1 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 58Carcinoma, Non-Small-Cell Lung 53Breast Neoplasms 19Pancreatic Neoplasms 11Small Cell Lung Carcinoma 9Ovarian Neoplasms 9Melanoma 9Colorectal Neoplasms 8Colonic Neoplasms 8Stomach Neoplasms 7Sarcoma 7Head and Neck Neoplasms 7Neoplasms 6Pleural Effusion, Malignant 5Mesothelioma 5Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 4Adenocarcinoma of Lung 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Osteosarcoma 3Neoplasm Metastasis 3Glioblastoma 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Rectal Neoplasms 2Pulmonary Disease, Chronic Obstructive 2NSCLC 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × NSCLC × Thoracic × Clear all
NCT06735508 2024-12-16

MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

Guangdong Provincial People's Hospital

Phase EARLY_PHASE1 Not yet recruiting
40 enrolled
Thoracic

NSCLC

NCT06685653 2024-11-12

Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients

Nanjing Tianyinshan Hospital

Phase EARLY_PHASE1 Not yet recruiting
65 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡